Role of human serum biotinidase as biotin-binding protein

Biochem J. 1988 Nov 15;256(1):265-70. doi: 10.1042/bj2560265.

Abstract

Biotinidase shows two binding sites for biotin, with Kd = 59 and 3 nM respectively, and requires tryptophan and cysteine residues of the biotinidase protein for biotin-binding activity. Analysis of human serum by various column-chromatographic techniques indicates that biotinidase is the only protein which exchanges with labelled (+)-biotin. It was shown previously that epileptic patients receiving a high average dose of anticonvulsants (containing a carbamide group) have lower biotin concentrations than those receiving a low dose. We have shown in human serum and with purified biotinidase that these anticonvulsant drugs compete with biotin for binding to the protein moiety.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amidohydrolases / blood*
  • Binding Sites
  • Biotin / metabolism*
  • Biotinidase
  • Bromosuccinimide / pharmacology
  • Carbamazepine / pharmacology
  • Carrier Proteins / metabolism*
  • Centrifugation, Density Gradient
  • Chloromercuribenzoates / pharmacology
  • Chromatography, Gel
  • Globulins / metabolism
  • Humans
  • Hydrogen-Ion Concentration
  • Phenobarbital / pharmacology
  • Phenytoin / pharmacology
  • Serum Albumin / metabolism
  • p-Chloromercuribenzoic Acid

Substances

  • Carrier Proteins
  • Chloromercuribenzoates
  • Globulins
  • Serum Albumin
  • biotin-binding proteins
  • Carbamazepine
  • p-Chloromercuribenzoic Acid
  • Phenytoin
  • Biotin
  • Amidohydrolases
  • Biotinidase
  • Bromosuccinimide
  • Phenobarbital